Cadmium containing compositions
CA 2377920 A1 · Owner: Cancer2 Inc. · Inventors: Woods, Gordon L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and compositions are provided for decreasing or regulating ratios of zinc:cadmium and PGE2:PGF2.alpha. and regulating the concentration of zinccontaining and PGE2-dependent matrix metalloproteinases in body fluids and tissues of a mammal, comprising administering to the mammal an amount of a pharmaceutically acceptable and bioavailable cadmium salt. Elevated or fluctuating levels of PGE2 and zinc and elevated concentrations of zinccontaining and PGE2-dependent matrix metalloproteinases have been found to be associated with the development of certain diseases.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 7, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 7, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 7, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.